Zuclopenthixol hydrochloride

This classification denotes the hydrochloride form of an antipsychotic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 47ISU063SG. European Medicines Agency schedules Zuclopenthixol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00195MIG. Zuclopenthixol generally arises in the molecular formula C22H25CLN2OS. The term ZUCLOPENTHIXOL is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 38, no. 6, 1984, list 24.) ZUCLOPENTHIXOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule zuclopenthixol hydrochloride under HS 29349990 and SITC 51579. As of Q4 2014, ZUCLOPENTHIXOL HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Zuclopenthixol hydrochloride bears US NLM identifiers UMLS ID C0350505 and NCI Concept Code C95837. SMILES: C1CCC2C(C1)/C(=C/CCN3CCN(CC3)CCO)/C4CC(CCC4S2)CL.CL.CL.